<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="80608">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01908647</url>
  </required_header>
  <id_info>
    <org_study_id>W81XWH-11-2-0180</org_study_id>
    <nct_id>NCT01908647</nct_id>
  </id_info>
  <brief_title>Using Real-Time Functional Brain Imaging to Enhance Recovery From TBI</brief_title>
  <official_title>Using Real-Time Functional Brain Imaging to Enhance Recovery From TBI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Van Boven, Robert W., M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Geneva Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Massachusetts Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Van Boven, Robert W., M.D.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this randomized, controlled clinical trial, we will evaluate the effects of (1) a
      brain-training program that uses real-time neurofeedback in functional magnetic resonance
      imaging (fMRI) to allow people to learn how to gain voluntary control over activity in
      targeted brain regions and/or (2) 8 weeks of computer-based cognitive training using a
      software program (Cognitive Remediation for Brain Injury (CRBI)) versus control training
      tasks on cognitive learning and symptoms.  In addition, the investigators will measure brain
      function (active and resting functional magnetic resonance imaging) and structure (high
      resolution magnetic resonance imaging) before and after treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Neuropsychological assessments</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>A composite score based on four primary domains (learning, memory, working memory and executive function).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participant-reported outcomes</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>A measure of the impact of program use on the participants' own view of their impairment and function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Working/School Status</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>A measure of participants' employment status, schooling status, and the number of hours worked/volunteered/in school per week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise Based Assessments</measure>
    <time_frame>4 and 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Three sets of assessments that are closely modeled on study-related exercises in the auditory, visual, and cognitive control modules, and include auditory speed of processing, visual speed of processing, and cognitive control speed of processing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Assessments</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Two types of functional measures: a sensitive directly observed performance measure designed originally for normal cognitive aging (timed instrumental activities of daily living, TIADL), and a well-accepted clinical impression measure (the Mayo-Portland Adaptability Inventory, MPAI-4).</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <condition>Post Traumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>Exp RT fMRI/Exp Cognitive Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Both experimental conditions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exp RT fMRI/Ctrl Cognitive training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental real-time fMRI and control cognitive training.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ctrl RT fMRI/Exp Cognitive Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Control RT fMRI (real-time functional MRI) and experimental cognitive training.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ctr RT fMRI/Ctr Cognitive Training</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Control real-time fMRI and control cognitive training.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>RT fMRI</intervention_name>
    <description>Real-time fMRI with neurofeedback.</description>
    <arm_group_label>Exp RT fMRI/Exp Cognitive Training</arm_group_label>
    <arm_group_label>Exp RT fMRI/Ctrl Cognitive training</arm_group_label>
    <other_name>Real-time fMRI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Training</intervention_name>
    <description>Computer based attention training.</description>
    <arm_group_label>Exp RT fMRI/Exp Cognitive Training</arm_group_label>
    <arm_group_label>Ctrl RT fMRI/Exp Cognitive Training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control RT fMRI</intervention_name>
    <description>Control condition for real-time fMRI.</description>
    <arm_group_label>Ctrl RT fMRI/Exp Cognitive Training</arm_group_label>
    <arm_group_label>Ctr RT fMRI/Ctr Cognitive Training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control Cognitive Training</intervention_name>
    <description>Computer-based games used as a control for the computer based cognitive training intervention.</description>
    <arm_group_label>Exp RT fMRI/Ctrl Cognitive training</arm_group_label>
    <arm_group_label>Ctr RT fMRI/Ctr Cognitive Training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mild TBI: PTA/confusionâ‰¤1 hour immediately after injury; or LOC &lt;30 min [69]
             confirmed by the Ohio confirmed by the Ohio State University TBI Identification
             Method-Short Form (OSU TBI-ID-SF).

          -  Age 18-45 years

          -  Right handed [70].

          -  Minimum of 4 months and within 36 months post-injury

          -  Can participate in fMRI and outcome assessment

          -  Adequate visual, auditory, sensory-motor function for training program.

          -  Fluent in English

          -  Persistent cognitive dysfunction confirmed by an objective measure

        Exclusion Criteria:

          -  History of hypoxic event

          -  Pre-existing significant neurological (e.g. MS) or psychiatric (e.g. schizophrenia,
             bi-polar) disorders.

          -  Current illicit drug use or ETOH abuse

          -  Contraindications to MRI (metal, pregnant, pacemaker, claustrophobia, etc.).

          -  Unwilling or unable (e.g. language barrier) to participate

          -  Hospitalization during study

          -  Current Med Board for discharge, Litigation/ + malingering test [71]

          -  Use of medications to enhance cognitive function (e.g. Ritalin)

          -  Initial Glascow Coma Score &lt;13 or penetrating head injury

          -  Subjects must not show suicidal ideation as measured by the Columbia-Suicide Severity
             Rating Scale (C-SSRS; 111). Subjects with a score of 4 or 5 (as recommended by the
             FDA for treatment trials) will be excluded and referred for appropriate treatment.

          -  Subjects should not be enrolled in a concurrent TBI clinical trial.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Van Boven, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Geneva Foundation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kaela Miller</last_name>
    <phone>737-346-7017</phone>
    <email>kmiller@genevausa.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Carl R Darnall Army Medical Center (CRDAMC)</name>
      <address>
        <city>Fort Hood</city>
        <state>Texas</state>
        <zip>76544</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Van Boven, M.D.</last_name>
      <phone>847-477-9317</phone>
      <email>robert.vanboven@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Michel-Alexis Courines, M.D.</last_name>
      <phone>254-288-8309</phone>
      <email>michel.a.courtines.mil@mail.mil</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Van Boven, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Greg S Harrington, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Satrajit Ghosh, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Gabrieli, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michel-Alexis Courtines, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 24, 2014</lastchanged_date>
  <firstreceived_date>July 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mTBI</keyword>
  <keyword>PTSD</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
